As I prepare for my annual trip to San Francisco to be a part of the excitement around the J.P. Morgan Healthcare Conference, I eagerly anticipate reconnecting with business partners, customers, and investors alike. My first trip to this city was back in 2005, and I have been coming ever since. One year that I vividly remember was the 2013 conference, where I discussed with early investors the idea of creating a company focused exclusively on biosimilars, envisioning the building of a modern, state-of-the-art facility long before it was needed. Now, 12 years later and with nearly $2 billion invested, I reflect on the incredible progress we have made and the journey of the company we named Alvotech. Annual events often serve as markers of growth and maturation. Just as we celebrate our children's birthdays or other yearly traditions, for me, Alvotech's growth is intertwined with the memories of my trips to San Francisco. Each year, the conversations about our venture have evolved, reflecting our challenges, achievements and future aspirations. But each year represents a step in our evolution. Today, we have launched two products in global markets, with multiple launches on the near-term horizon. We have an expansive pipeline in development and a top-notch team of scientists and professionals that work tirelessly to provide the world with biosimilars, a crucial component in the sustainability of healthcare systems. The importance of biosimilars cannot be overstated—they provide affordable alternatives to biologic drugs, significantly reducing healthcare costs and increasing patient access to essential treatments. Beyond affordability, biosimilars drive innovation by introducing much-needed competition into the market. This competition fuels a dynamic ecosystem of innovation, a vibrant energy that is palpable in the many companies that converge in San Francisco every January. As I look forward to next week, I am filled with pride in what we have accomplished and excitement for the future. And, of course, I am hoping for good weather in San Francisco! ?? #biosimilars #biologics #innovation #Alvotech #JPM2025 Image: ?Justin Mier
Congratulations and All the best ??
Congratulations on the launches and best wishes
Thanks for sharing. Best wishes
Marketing, PR / MBA
2 个月Godspeed